Table II. Correlation of cholesterol efflux activity with MS spectral counts.
| Efflux Peak 1 |
Efflux Peak 2 |
Efflux Peak 3 |
||||||
|---|---|---|---|---|---|---|---|---|
| r | p | r | p | r | p | |||
| apolipoprotein B | 0.944 | 4.29E-09 | apolipoprotein A-II | 0.993 | 2.36E-16 | antithrombin-III | 0.967 | 6.88E-11 |
| IGHM | 0.912 | 1.31E-07 | Ig kappa chain C region | 0.978 | 3.02E-12 | α-1-antitrypsin | 0.965 | 1E-10 |
| C4b-binding protein α chain | 0.749 | 0.0003 | Ig gamma-1 chain C region | 0.974 | 1.02E-11 | transthyretin | 0.958 | 4.1E-10 |
| fibrinogen α chain | 0.720 | 0.0008 | apolipoprotein A-I | 0.951 | 1.46E-09 | albumin | 0.935 | 1.35E-08 |
| fibrinogen β chain | 0.710 | 0.0010 | serum amyloid P | 0.944 | 4.16E-09 | α-1-acid glycoprotein 1 | 0.849 | 8.39E-06 |
| fibrinogen γ chain | 0.709 | 0.0010 | complement C3 | 0.894 | 5.83E-07 | serotransferrin | 0.836 | 1.55E-05 |
| apolipoprotein(a) | 0.564 | 0.0147 | inter α trypsin inhibitor 4 | 0.838 | 1.41E-05 | α-1-acid glycoprotein 2 | 0.830 | 2.04E-05 |
| apolipoprotein C-I | 0.832 | 1.87E-05 | apolipoprotein H | 0.826 | 2.37E-05 | |||
| apolipoprotein J | 0.764 | 0.0002 | angiotensinogen | 0.765 | 0.0002 | |||
| paraoxonase 1 | 0.760 | 0.0003 | vitamin D binding protein | 0.754 | 0.0003 | |||
| apolipoprotein D | 0.658 | 0.0030 | apolipoprotein A-IV | 0.697 | 0.0013 | |||
| PtdIns-glycan-specific phospholipase D | 0.646 | 0.0038 | kallistatin | 0.690 | 0.0015 | |||
| ceruloplasmin | 0.614 | 0.0067 | retinol binding protein 4 | 0.684 | 0.0017 | |||
| lecithin:cholesterol acyltransferase | 0.564 | 0.0149 | gelsolin | 0.655 | 0.0032 | |||
| complement C2 | 0.560 | 0.0157 | zinc-α-2-glycoprotein | 0.650 | 0.0035 | |||
| lumican | 0.530 | 0.0238 | α-2-HS-glycoprotein | 0.622 | 0.0059 | |||
| plasma kallikrein | 0.505 | 0.0327 | plasminogen | 0.617 | 0.0064 | |||
| hemopexin | 0.563 | 0.0149 | ||||||